Université d’État d’Haïti
E-Bibliothèque | Catalogues & Ressources

Bienvenue à la E-Bibliothèque de l’UEH

Bénéficiez l'accès à des milliers de ressources en ligne

Image from Google Jackets
Image from OpenLibrary

Guidance document : administrative processing of submissions and applications involving human or disinfectant drugs.

Contributor(s): Material type: TextPublisher: Ottawa, ON : Health Canada = Santé Canada, 2020Copyright date: ©2020Description: 1 online resource (24 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780660358901
  • 0660358905
Subject(s): DDC classification:
  • 363.19 15
Other classification:
  • cci1icc
Online resources: Summary: "Pursuant to Part C, Division 1 and Division 8 of the Food and Drug Regulations (hereafter the Regulations), no manufacturer shall sell a drug in Canada unless a Drug Identification Number (DIN) [C.01.014 (1)] or DIN and Notice of Compliance (NOC) [C.08.002 (1)] have been issued by Health Canada, which grants market authorization for that product. Manufacturers must notify Health Canada of information changes pertaining to the manufacturer and drug product as set out by paragraph C.01.014.4 (b) of the Regulations"--Introduction, page 7.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Distributed by the Government of Canada Publishing and Depository Services Program (Weekly acquisitions list 2020-44).

Issued also in French under title: Ligne directrice : Traitement administratif des présentations et des demandes concernant les médicaments destinés aux humains ou les désinfectants.

"October 2020."

"Pub.: 200167."

Includes bibliographical references.

Unrestricted online access. Unrestricted online access. star CaOONL

Electronic monograph in PDF format.

"Pursuant to Part C, Division 1 and Division 8 of the Food and Drug Regulations (hereafter the Regulations), no manufacturer shall sell a drug in Canada unless a Drug Identification Number (DIN) [C.01.014 (1)] or DIN and Notice of Compliance (NOC) [C.08.002 (1)] have been issued by Health Canada, which grants market authorization for that product. Manufacturers must notify Health Canada of information changes pertaining to the manufacturer and drug product as set out by paragraph C.01.014.4 (b) of the Regulations"--Introduction, page 7.

There are no comments on this title.

to post a comment.
Share

Bibliothèque universitaire de l'UEH
Portail centralisé donnant accès au catalogue, aux ressources numériques et aux productions scientifiques de l’Université d’État d’Haïti.

🛠 Support & Aide

© 2026 UEH – E-Bibliothèque de l’Université d’État d’Haïti | À propos | Confidentialité | Conditions | Mentions légales | Accessibilité | Plan du site